Outstanding issues in use of disease-modifying agents in rheumatoid arthritis
Lancet
.
1999 Jan 23;353(9149):257-8.
doi: 10.1016/s0140-6736(05)74938-2.
Authors
R Madhok
1
,
H A Capell
Affiliation
1
Centre for Rheumatic Diseases, Royal Infirmary, Glasgow, UK.
PMID:
9929016
DOI:
10.1016/s0140-6736(05)74938-2
No abstract available
Publication types
Comment
MeSH terms
Antirheumatic Agents / adverse effects
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Humans
Treatment Outcome
Substances
Antirheumatic Agents